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ABSTRACT

Calcific Aortic Valve Disease (CAVD) is a major disorder in the developed
countries among elderly. It is characterized by calcific deposition and stiffening of the
aortic valve cusps. CAVD is a highly cell-mediated condition where valvular interstitial
cells (VICs) become activated and differentiate into osteoblast-like cells. This is
associated with upregulation of calcific markers like Alkaline phosphatase (ALP) and
Runx2. ECM remodeling in another characteristic of stenotic aortic valves due to VIC
activation. Reports show that CAVD initiates majorly on the noncoronary side of the
aortic valves. Additionally, male sex is a significant risk factor of CAVD. Aortic valves
are surrounded by a complicated hemodynamic environment. Pathological levels of
mechanical forces applied to the aortic cusps interact with the VICs’ remodeling and
differentiation and lead to abnormalities within the aortic cusps.
In this dissertation, comparative studies were performed among VICs isolated
from individual aortic cusps or between male and female to verify whether the
differences in aortic calcification are observed at a cellular level. The calcification of
VICs isolated from coronary and noncoronary aortic cusps was investigated in osteogenic
culture condition to identify whether VICs show different amounts of calcific markers.
Moreover, the osteogenic differentiation of VICs isolated separately from male and
female aortic valves was analyzed to find if there are sex-related differences in their
proliferation and calcification. Finally, both hypotheses were tested under cyclic strain to
iv

determine the impact of pathological vs. physiological strain on enhancing the VICs
calcification among coronary and noncoronary cusps or between male and female valves.
It was found that VICs isolated from noncoronary cusps demonstrated greater
calcification potential than coronary cusps. Likewise, male VICs showed increased ECM
remodeling compared to female. Pathological cyclic strain applied to VICs cultured in
osteogenic condition enhanced their calcification, however VICs cultured in normal
condition seem not to be affected by pathological cyclic strain.
The results from this dissertation provide a new perspective on the biomolecular
events associated with VICs calcification. It shows that VICs in different cusps of an
aortic valve have heterogeneous populations. Furthermore, it confirms that sex of the
cells matter in aortic valve calcification.

v

“There is still need to think and plan, but on a different scale, and along different lines.”
C.S Forester (1899-1966), The Hornblower companion
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CHAPTER ONE
INTRODUCTION

1

Significance:
For decades, Calcific Aortic Valve Disease (CAVD) was believed to be a passive
degenerative condition. However, it is now well-accepted that CAVD is an active and
highly cell-mediated process [1, 2]. This disease affects approximately 26% of the
population over 65 years old and results in enormous cost for surgeries and medical care
[3]. CAVD is a general term addressing all forms of aortic valve calcification including
aortic sclerosis and stenosis. Aortic stenosis is the most prevalent heart valve disorder
which in advance stages contributes to more severe heart disorders. Currently the only
viable treatment for patients with major stenosis conditions is aortic valve replacement.
Also, there is no method for early diagnosis and prevention of the disease progression.
Every year 275,000 valve replacements are performed due to heart valve diseases
worldwide with 82,000 replacements in only US [4]. With increasing number of patients
with CAVD and complications associated with valve replacement and implant failure,
there is a critical need to find an alternate treatment for CAVD.

1.1 Aortic valve
The aortic valve is located between the left ventricle and the ascending aorta. It
prevents the blood backflow into the left ventricle during diastole. The aortic valve opens
and closes about 40 million times per year and 3 billion times in an average lifetime. In a
normal heart, the configuration of an aortic valve includes three cusps that attach to the
aortic wall in a semilunar form, ascending to their commissures. Behind each cusp there
2

is a pocket called sinus of Valsalva. The aortic cusps are named with respect to their
position toward the coronary arteries. The left and right coronary cusps face coronary
inlets within their respective sinus of Valsalva whereas non-coronary faces no inlet. The
microstructure of aortic cusps displays three different layers: Fibrosa on the aorta side in
is the load-bearing component of the aortic valve with a network of collagenous crimps
that enables valve opening in stress free condition; Spongiosa in the middle functions as a
damper mostly consists of Glycosaminoglycans (GAGs), and Ventricularis facing the left
ventricle with arranged elastin fibers with a small amount of collagen fibers (Figure 1.1)
[5].

1.2 Valvular interstitial cells (VICs)
The dominant cell population within the aortic heart valves is valvular interstitial
cells (VICs). They are distributed non-uniformly among the aortic cusp layers with the
highest density in fibrosa and the lowest in spongiosa. VICs are a heterogeneous
population of fibroblasts with different sub-phenotypes. Overall, five distinct VIC
phenotypes have been identified at different s conditions: eVIC (Embryonic Progenitor
endothelial/ Mesenchymal Cells), qVICs (quiescent) , pVICs (mesenchymal progenitor),
aVICs (activated) and obVICs (osteoblastic) [5]. Adult VICs are majorly quiescent
fibroblasts with a limited population of mesenchymal progenitor cells that have the
capability of multiple lineage differentiation, most likely into myofibroblasts (activated)
and osteoblast-like (osteoblastic) cells [6]. These two cell types are extensively seen
within the diseased aortic valve transplants. Myofibroblasts are characterized by
3

significant expression of α-smooth muscle actin (α-SMA). Likewise, osteoblast-like VICs
are characterized by osteogenic markers expression like alkaline phosphatase (ALP) [7].

Figure 1.1 Aortic cusp layers, rat aortic valve H&E staining

1.3 Origin of the aortic valve
During cardiogenesis, valves are formed in four stages: endocardial cushion
formation,

epithelial-to-mesenchymal

transition

(EMT),

valve

primordia,

and

diversification of cell types/maturation. Endocardial cushion is a mesenchymal outgrowth
4

that makes the aortic valve cusps, after the heart looping is completed. Notch1 signaling
pathway is required for the endocardiac cushion development [8]. Neural crest cells
(NCCs) in the endocardiac cushion regulate the outflow septation, the stage after which
the aorta, pulmonary artery and the valves are formed [9]. NCCs are distributed among
the aortic valve cusps during and after the septation. At the maturation stage of the valves
that will result in diverse phenotypes of the valve cells, NNCs differentiate

into

mesenchymal cells via a complex pathway that will ultimately lead to VICs within the
aortic valves. However, a study showed that majority of NCCs are exclusively present in
the aortic valve septal cusps which corresponds to left and non-coronaty cusps,
suggesting that VICs in distal cusp which corresponds to right coronary might originate
from another migratory embryonic cell type [10].

1.4 Calcific aortic valve disease (CAVD)
CAVD is a highly cell-mediated disorder in which VICs become activated and
contribute to the disease progression. CAVD is marked by calcific deposits within the
aortic valve cusps. At the early stages of the disease or aortic sclerosis, inflammation and
thickening of the cusps is noticed, whereas in advanced stage of the disease or aortic
stenosis, large calcium nodules can be seen within the cusps (Figure 1.2). Although much
remains to be learned about the etiology of CAVD, analyses of calcified human valve
explants have identified number of effective characteristics of CAVD, such as: presence
of inflammatory cells/molecules, angiogenesis, lipid deposition, extracellular matrix

5

disarray, elevated cellular migration, proliferation and apoptosis, and increased
transforming growth factor- β (TGF- β1) expression [1, 11, 12].

Figure 1.2 Different stages of CAVD: sclerosis (left), stenosis (right) [2]

Initiation of CAVD is related to trapping of low density lipoprotein (LDL) from the
blood. Studies have shown that the proteoglycans within the aortic cusps are preferred
sites for LDL accumulation. The entrapped LDLs transform into oxidatively modified
LDL (oxLDL) and induce oxidative stress to the Valvular endothelial cells (VECs). This
is followed by macrophage infiltration and activation [12] and release of

matrix

degrading enzymes such as matrix metalloproteinase (MMPs) and their tissue inhibitorstissue inhibitors of metalloproteinase (TIMPs)- and Cathepsin S [11, 13]. Abnormal
extracellular matrix (ECM) degradation and synthesis activates the residing VICs which
6

is associated with increased secretion of osteogenic cytokines, most importantly ALP,
TGF-β1 [14, 15] and bone morphogenetic protein-2 (BMP-2) [16, 17].

1.5 Sex/gender as a risk factor
CAVD has number of identified risk factors such as age, male sex, smoking,
hyperglycemia. Male sex is one of the most important risk factors for CAVDs; however,
the molecular mechanisms that make male more susceptible to aortic valve complications
are under investigated. Men have two fold excess risk of CAVD compared to women.
Reports have shown that women, in general, develop CAVD 7-10 years later than men
[18]. However, prevalence of CAVD increases drastically after menopause. It can be
hypothesized that the loss of estrogen, which is an aspect of postmenopausal ovarian
function, leads to cardiovascular dysfunction in older women [19, 20].
The sex difference in vascular disease is determined by the steroidal hormones and
their cell receptors SSHRs. The biological process of steroidal hormones’ involvement in
CVDs in general is complicated; both estrogen and testosterone receptors exist in
cardiovascular cells. These receptors are members of the nuclear hormone receptor
superfamily and can directly bind to DNA and regulate the expression of some adjacent
genes, thus categorized as transcription factors [21].
Not much is known about the pathological events of CAVD related to the sex at the
cellular level. To our knowledge, sex steroid hormones’ effect on valvular tissue and cells
in both sexes has not been reported.

7

1.6 Mechanical forces on valve calcification
Mechanical forces are an important component in the physiological microstructure.
Aortic valve faces complex mechanical forces in each systolic cycle, including tensile
stretch, bending stretch, fluid shear stress and varying pressures (Figure 1.3) [5]. During
diastole, the tissue of the cusps is stretched via a backpressure. During systole, the cusp
tissue becomes relaxed and shortens as a result of recoil of the elastin in ventricularis,
which was elongated and taut during diastole.
Consequently, the resident VICs are exposed to various mechanical forces exerted
on valve tissue, most importantly tensile stretch [22]. Part of the tensile stretch enforced
on VICs is due to the high blood overpressure in diastole, the other is due to outflow in
systole when the cusps are subjected to high pulsatile shear stress. The VICs are designed
to function under physiological mechanical forces. However, any abnormal changes in
the mechanical forces experienced by the VICs will result in pathological condition,
which leads to ECM remodeling and ultimately calcification [23]. Calcific deposits in
aortic valve occur in the regions with the highest functional valve stresses [24]. The
asymmetric configuration of a normal tricuspid aortic valve with coronary inlets in two of
the three cusps, result in variation in mechanical forces experienced by different parts of

8

Figure 1.3 Aortic valve cusps subjected to different mechanical forces at each systolic
cycle [1]

9

one aortic valve. Studies have confirmed that different parts of the aortic valve
experience different amounts of mechanical force at each cycle [25, 26].
Studying the VICs’ behavior is essential for achieving a thorough understanding of
the underlying events in stenotic conditions; however, this requires mimicking the
mechanical forces experienced by VICs in vitro. This has been accomplished by
commercial and custom-made bioreactors that can apply predefined physiological forces
to cells and tissues in a laboratory culture environment.
Flexcell® system is a commercially available bioreactor designed to apply strain on
the cultured cells in a sterile chamber to simulate the stretch. The system comprises of a
base plate, pump, controller, computer and monitor, and culture plates (Figure 1.4). The
culture plates are exclusive for this bioreactor, named Bioflex® plates made of flexible
bottom in their well. Various culture plate designs are available including uniaxial and
circumferential strain plates. The software provided in the system is capable of applying
different forms of strain on the well plates at varying extents. Moreover, the culture plates
can be coated with different ECM proteins such as collagen I.
Flexcell® bioreactor functions based on a simple model that incorporates applying
a vaccum. The plates are fixed on their baseplates. A vacuum is attached to the baseplate
pulling the outer ring of the cultured well and applying strecth to the inside area.

10

Figure 1.4 Flexcell® system components
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CHAPTER TWO
A REVIEW OF SEX-RELATED STUDIES ON MAJOR
HEART VALVE DISEASES AND ATHEROSCLEROSIS

12

A version of this chapter has been published as:
Masjedi S, Ferdous Z. Understanding the Role of Sex in Heart Valve and Major
Vascular Diseases. Cardiovascular engineering and technology. 2015;6(3):209-19.
Springer

2.1 Introduction
It is well accepted that there is difference in the prevalence and severity of major
cardiovascular disorders among men and women. Male has been classically considered a
risk factor in cardiac disorders. The molecular mechanism behind sex’s role in the
initiation and progression of heart valve diseases and atherosclerosis has barely been
investigated.
In chapter 1, I presented the microstructure of the aortic valve. Three thin layers are in
each aortic cusp (Figure 2.1A): Fibrosa in the aortic side consists of densely oriented
fibers of type I and type III collagens; Spongiosa in the middle mainly consists of
proteoglycans and glycosaminoglycans with some collagen fibers; and Ventricularis on
the ventricular side consists of a network of radially oriented elastin fibers [27]. In the
mitral valve, the two leaflets are attached to the myocardial membrane by a series of
tendon-like structures, called chordae tendinae (Figure 2.1B). The normal mitral leaflet
layers are: Fibrosa, Spongiosa, and Atrialis facing the left atrium; whereas the chordae
tendinae contains large number of longitudinally oriented collagen fibers [28].
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The blood vessel structure consists of three layers: Intima, a layer of endothelial
cells in direct contact with the blood flow and an underlying connective tissue; Media,
sheets of smooth muscles with connective tissues in between; and Adventitia, a layer of
fibrous connective tissue covering the outermost part of the vessels (Figure 2.2 A,B) [29].
Previously, aortic valve stenosis was believed to be a passive condition resulted from
atherosclerosis. This statement was due to numerous similarities between CAVD and
atherosclerosis. The major similar characteristics of the two conditions include but not
limited to:
-

Shared risk factors such as male sex, smoking, diabetes, hyperglycemia,..

-

Calcium deposition within the tissue

-

Expression of similar enzymes and growth factors like ALP, BMPs, Osteopontin

Previous studies compared the cultured VICs and vascular smooth muscle cells (VSMCs)
differentiation and deformation in pathological conditions [30]. However, the sex-related
cellular mechanism which expose male to excess risk have not been investigated in VICs
and barely investigated in VSMCs. Similarly, no comparative sex-related study has been
performed among heart valve disorders and atherosclerosis. The similar pathophysiology
of these disorders motivated us to review previous sex-related studies on aortic stenosis,
mitral valve prolapse and atherosclerosis.

2.2 Aortic Stenosis
Aortic stenosis refers to the deposition of calcium within the aortic valve tissue [5,
6, 31]. Majority of early sex/gender-difference studies on aortic stenosis focused on the
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Figure 2.1 (A) aortic cusp layers, (B) mitral leaflet layers, porcine aortic valves H&E
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Figure 2.2 (A) Aorta cross-section, (B) vascular layers from aorta, rat H&E
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effect of aortic stenosis on the myocardium, most importantly on left ventricular (LV)
hypertrophy and LV degeneration, but not on the diseased aortic valve. For example, in a
study by Carroll et al. on patients over 60 years with aortic stenosis, women’s LV
response was more adaptive, while men’s cardiac performance (quantified by defined
cardiac function indexes) was more frequently depressed [32]. Nordmeyer et al.
investigated sex-dependent alterations in myocardial estrogen receptor and hypertrophyrelated gene expression in human aortic valve stenosis [33]. Estrogen receptors (ER) are a
subgroup of Sex Steroid Hormone Receptors (SSHRs) expressed in mouse myocytes,
fibroblasts, and human heart cells. The authors showed that α-ER and β-ER mRNA
increased in human hearts with aortic stenosis. While α-ER mRNA content among men
and women were comparable, β -ER mRNA content was significantly greater in women
than men (47% vs. 28%) with respect to controls. This suggested a link between β-ER
expression and greater aortic stenosis in women [33].
Other studies measured sex difference in the biomolecular turnover in LV
myocardium during aortic stenosis. Regitz-Zagrosek et al. reported that the overload
pressure in left ventricle led to increased extracellular matrix (ECM) remodeling and
collagen I, III, and fibronectin deposition in early stages of aortic stenosis [34]. Similarly,
Skavdhal et al. studied the role of ER subtypes by inducing aortic stenosis condition in
male and female mouse models [35]. They found that the female wild type mice had
significantly lower induced hypertrophy in response to pressure overload as compared to
male mice. Additionally, β-ER attenuated response to pressure overload in female mice.
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[36]. More comprehensive discussion on LV pathophysiology and changes in myocytes
due to hypertrophy and role of sex hormones can be found in excellent review by RegitzZagrosek and Seeland [37].
Even though majority of sex studies on aortic stenosis focused on the heart,
Aggarwal et al. used multidetector CT imaging to evaluate the severity of aortic stenosis
among men and women. They found that aortic valve calcification is significantly lower
in women compared to men at all stages even after accounting for their smaller body size.
This work, however, did not offer any information on impact of sex/gender on the
pathogenesis of aortic stenosis [38]. Another study by McCoy et al. on aortic valvular
interstitial cells identified 183 genes to be significantly different in male vs. female
healthy porcine aortic valves, many of them relevant to pathways activated in HVD. They
concluded that the greater occurrence of HVD in male may originate from their genetic
propensity to develop HVD at the cellular scale [39]. Similarly, data from our laboratory
(in chapter 4) indicate a difference in ECM remodeling and early calcific marker
expression such as alkaline phosphatase, between male and female valvular cells derived
from rats. With growing awareness on the role of sex in HVDs, we anticipate more
research will elaborate on the sex-difference in aortic stenosis in the near future.

2.3 Mitral Valve Prolapse
Mitral valve prolapse (MVP) is often associated with a number of ruptured chordae
tendineae, myxomatous thickening and tissue remodeling [40]. In advanced stages of
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MVP, mitral regurgitation (MR) occurs with high possibility of heart failure. In fact,
according to epidemiological studies, MR is the most common HVD [41, 42]. MR
frequently occurs due to progression of myxomatous changes in valves with chronic
prolapse conditions [43, 44].
The major risk factor for myxomatous mitral valve disease is age; however, a few
sex/gender-difference studies in humans or dogs are available. In one of the early studies,
Lax et al. reported that mitral valve prolapse occurs more frequently in women by testing
a hypothesis that mild dehydration induces mitral valve prolapse [45, 46]. The interesting
observation in these studies was that 50% of the women showed MVP symptoms,
whereas only 10% men were affected. Even after considering the anatomical differences
between female and male mitral valve leaflets and annulus, it could be concluded that
MVP induced by dehydration is more likely to happen in healthy women than in men. In
contrast, a separate study performed on a population with different body habitus, Savage
et al. showed no significant difference in mitral valve prolapse between female and male
in asthenic patients [47]. In another study, Avierinos et al. used a population of male and
female patients with different stages of MVP: no regurgitation, with mild prolapse, and
moderate or severe regurgitation [48]. They also accounted for the number of surgeries
and the mortality rate in male and female. They found that women had significantly
greater number of anterior and bileaflet prolapse, leaflet thickening (32% vs. 28%), lower
posterior prolapse (22% vs. 31%), flail (2% vs. 8%), and severe regurgitation (10% vs.
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23%) than men (p<0.001). Therefore, they concluded that women had a higher likelihood
of getting MVP and at a younger age than men.
Sex and gender difference studies on MR have also been very limited; however, a
few clinical studies have identified male [43, 49] or, female [50-53] as risk factors for
MR. Singh et al. designed a clinical study with two groups of patients: one with severe
MR due to MVP and a group of randomly selected patients with MVP [44]. Their
findings showed a lower cumulative risk of surgery for women with MVP than men
(0.8% vs. 2.6%) before age 65 and (1.4% vs. 5.5%) by age 75. In another populationbased study, Jones et al. studied various MR risk factors in American Indian population
[54]. They divided the participants by MR severity level and concluded that MR is
independently associated with female sex, lower body mass index, older age and renal
dysfunction. Likewise, Wilcken et al. performed a cohort study on Australian men and
women that were at risk of MVP [55], and combined that with a clinical study on patients
that had mitral valve surgery due to myxomatous mitral disease. The goal of this study
was to estimate the cumulative risk of developing severe MR due to MVP in men and
women. Their result showed that before age 50, the risk was low in general; however,
men over 50 were at an increased risk of MR. In all age groups (50s, 60s and 70s), the
risk in women was less than half of that in men [43].
The contradicting results on the above population-based studies on MVP/MR are
not surprising, since it is difficult to isolate other variables and risk factors in clinical
studies. Perhaps studies on the cellular/molecular mechanisms in MVP could shed light
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on the sex-difference in this disease. Unfortunately, the authors were surprised to see the
lack of literature in this area. In fact, we found only one report by Grande-Allen et al. that
studied the difference in the abundance of a major proteoglycan versican among the male
and female patients with myxomatous disease. [56]. Sex-difference was apparent in both
normal and myxomatous valves: in normal valves, versican amount was higher in female
than in male; in myxomatous samples, versican was higher in male. In addition, when the
abundance of total proteoglycan (Decorin, Biglycan and Versican) was measured in
myxomatous valves, male showed a trend of greater total proteoglycan than female
valves.

2.4 Atherosclerosis
Atherosclerosis is a chronic inflammatory disease with a similar mineralization
process as aortic stenosis [57-59]. In later stages of atherosclerosis, vascular smooth
muscle cells (SMCs) differentiate into osteoblast-like cells, and express proteins involved
in bone formation, such as bone morphogenic protein (BMP)-2, osteopontin (OPN),
matrix gla protein (MGP), and osteoprotegerin (OPG) [57]. A number of studies have
reported some differences in the manifestations of atherosclerosis in male vs. female [58,
60-62]. Even though majority of these studies were based on clinical or epidemiological
data, some recent reports investigated role of biomolecular factors in sex-dependent
behavior of SMCs in atherosclerotic condition. For example, reactive oxidative species
(ROS) contributes to atherosclerosis by enhancing oxidative stress and apoptosis [63-65].
However, only a few studies have investigated the effects of sex on the oxidative stress in
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isolated vascular SMCs. Malorni et al. exposed freshly isolated male and female vascular
SMCs to UV radiation as oxidative stress inducer. They reported that male cells produced
significantly greater amounts of hydrogen peroxide and superoxide anion, both important
ROS molecules. Additionally, they showed that male cells had more cytoskeleton
damage due to UV radiation, which might lead to their increased apoptosis [66]. In their
recent study, they further analyzed female cells’ apoptotic resistance by studying their
behavior in anoikis, a type of cell apoptosis, via detachment from substrate. Their results
confirmed that number of detached cells in female were lower both prior to UV radiation
and after radiation [67].
A series of studies have shown sex-dependent interactions between SMCs and
Nitric Oxide (NO), a molecule known to inhibit the development of neointimal
hyperplasia [68, 69] . Hogg et al. evaluated the efficacy of NO at inhibiting the vascular
SMC proliferation, migration and cell cycle progression in vitro, as well as neointimal
hyperplasia in vivo. They reported that NO effectively inhibited proliferation, migration
and cell cycle arrest in both sexes; however, male SMCs showed stronger response in
both hormone-replete and –deplete conditions than females. Similarly, their rat models
treated with weight-dependent dosage of NO showed reduced neointimal hyperplasia in
males than females. Furthermore, their rat models with carotid artery injury in
hormonally intact or, castrated rats were in continuance with the in vitro study [68]. To
determine the underlying causes for these sex differences, the authors further studied the
role of ER on proliferation of male and female vascular SMCs following exposure to NO.
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They observed that both α-ER and β-ER repressed proliferation in males, whereas only βER was effective in females. Since NO signals through ERs, it was less effective in
reducing neointimal hyperplasia in female [69].
Another marker OPN, a non-collagenous adhesive protein in bone matrix [57, 70],
promotes atherosclerotic lesions in early stages, but inhibits mineral deposition in later
stages by attaching to the apatite crystal and preventing its growth [58, 71, 72]. Using
mice deficient in both OPN and apolipoprotein E, Matsui et al. showed that female wild
type mice had significantly larger atherosclerotic lesions compared to the knockout mice,
suggesting they are at greater risk for atherosclerosis. No notable difference among male
mice genotypes was observed in their study [58].
Other studies have focused on lipoprotein(a) [73, 74], a major risk factor for
atherosclerosis and coronary heart disease [75]. High levels of plasma lipoprotein(a)
correlate to early stages of coronary atherosclerosis predominantly in men [73, 74]. In a
population-based study, Shreiner et al. compared plasma lipoprotein(a) levels to
preclinical carotid atherosclerosis in middle-aged (45 to 64) white and black male and
female patients by measuring their carotid wall thickness [73]. In this study, other risk
factors such as smoking, diabetes and menopause were also considered. They reported
that white men on average had the greatest mean carotid intimal-medial far-wall
thickness among the four race/sex groups (0.798 mm compared to 0.779, 0.718, and
0.695 mm in black men, black women, and white women, respectively). In Black women
with diabetes, the lipoprotein(a) was significantly associated with wall thickness;
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however, this association was not observed for non-diabetics. For white women, the
association between lipoprotein(a) and wall thickness depended mostly on smoking status
with nearly statistical significance. In general, they reported a correlation between
lipoprotein(a) and carotid wall thickness in the preclinical atherosclerotic disease;
however, this association was heavily affected by other risk factors. Nonetheless, in the
absence of major risk factors, women had lower carotid wall thicknesses and lower
amount of lipoprotein(a) in their blood compared to men. Stensland-Bugge et al. similarly
employed ultrasonographic scanning to determine sex and age differences in carotid
atherosclerosis by measuring carotid artery intima-media thickness [76]. Their results
showed that in all age groups (25-40, 40-60, >60), men had a thicker mean intima-media
layer than women, and this difference increased significantly with age. In addition, this
study suggested fibrinogen as a strong risk factor in men than women. Another risk
factor, physical activity, reduced the risk of cardiovascular disease in men, but had no
significant effect on women [77]. When low, medium and high level of physical activity
in each group was compared, medium physical activity had the most significant
protective effect against CVD in men. Alternatively, a different study showed that low
physical activity at work led to elevated incidents of stroke and death in women [78]. In
another study by Stensland-Bugge et al., triglycerides strongly correlated with subclinical
atherosclerosis in women than in men [76]. While previous studies have linked serum
triglycerides levels and high-density lipoprotein cholesterol [79-81], this study reported
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that intima-media thickness and triglycerides in women was independent of high-density
lipoprotein cholesterol levels [76].

2.5 Summary
As reviewed in this chapter, male is a significant risk factor for CAVD and
atherosclerosis. Comparatively, the sex-related investigations on the pathology of CAVD
and atherosclerosis suggest similarities in the molecular events in the diseases initiation
(endothelia cell activation) and progression (osteogenic differentiation and presence of
osteoblast-like cells in calcific lesions). However, in mitral valve disorders females were
reported to be at a higher risk. Table 2.1 summarizes the prevalence of the reviewed
cardiovascular disorders among men and women.

Table 2.1 Prevalence of Cardiovascular Diseases in Men and Women

Disorder

Male

Female

Aortic Stenosis

A recognized risk factor

Mitral Valve prolapse

Increased ECM production

Shows increased left
ventricular hypertrophy
after menopause
Clinically at higher risk

Atherosclerosis

Greater risk in men

25

Larger atherosclerotic
lesion in OPN deficient
female mice

CHAPTER THREE
COMPARISON OF CALCIFICATION POTENTIAL OF
VALVULAR INTERSTITIAL CELLS ISOLATED FROM
INDIVIDUAL AORTIC CUSPS

26

A version of this chapter has been published as:
Masjedi S, Amarnath A, Baily KM, Ferdous Z. Comparison of calcification
potential of valvular interstitial cells isolated from individual aortic valve cusps.
cardiovascular pathology. 2016;25: 185–94. Elsevier

Abstract:
Calcific aortic valve disease (CAVD) is one of the most prevalent disorders among
the elderly in the developed countries. CAVD develops via cell-mediated processes, and
clinical data show that CAVD initiates mostly in the noncoronary cusp of the aortic
valve. Valvular interstitial cells (VICs) populate the inside of heart valves and are a
heterogeneous cell population. The goal of this study is to elucidate the difference in
calcification potential among VICs isolated from the left, right, and noncoronary cusps of
porcine aortic valves.
VICs were isolated from each of the aortic valve cusps and cultured in calcifying
medium for 14 days to induce calcification. The samples were assessed for calcium
deposits, nodule formation, and calcific markers using alizarin red and Von Kossa
staining, alkaline phosphatase (ALP) staining, ALP enzyme activity assay, and western
blot. Extracellular matrix (ECM) production and degradation was measured using
collagen and glycosaminoglycan (GAG) assay and gelatin zymography. We observed
that VICs isolated from the noncoronary cusp expressed greatest amount of the above
calcific markers as compared to the coronary cusps. Also, collagen and GAG content was
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the greatest in noncoronary VICs. However, our zymography results showed significant
difference only for active Matrix metalloproteinase-2 (MMP-2) expression between right
and noncoronary VICs.
Our results suggest that VICs among the three cusps within aortic valve might be
inherently different, where a subpopulation of VICs might be predisposed to
calcification.
Keywords: Calcific aortic valve disease, coronary and noncoronary cusps, valvular
interstitial cells, calcification

3.1 Introduction
Calcific aortic valve disease (CAVD) refers to a major disorder ranging from mild
inflammation within the aortic valve cusps (aortic sclerosis) to severe calcific nodule
formation in the aortic valve tissue (aortic stenosis) [5]. These two conditions affect 26%
and 2% of the population over 65 years in the developed countries, respectively [3, 4,
82]. End-stage aortic stenosis is associated with life-threatening outcomes, such as left
ventricular hypertrophy [83, 84]. Unfortunately, the underlying events associated with the
initiation and progression of CAVD is not fully understood.
It has been reported that CAVD is a highly active condition mediated by valvular
interstitial cells (VICs), the dominant cell population in heart valve tissue. In the aortic
valve, VICs are distributed non-uniformly among the three valve layers—the
ventricularis, fibrosa, and spongiosa—the fibrosa layer has the highest and spongiosa
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layer the lowest cell density [1]. Numerous studies have shown that VICs have a
heterogeneous cell population among the four heart valves and also in different locations
within each valve [5, 7, 85, 86]. VICs were initially believed to mainly consist of
fibroblast and myofibroblast characteristics [7, 87]. Recently, VICs have been
categorized into a major population of quiescent VICs with a small subpopulation of
progenitor VICs and osteoblast-like VICs [7]. The mesenchymal progenitor VICs have
limited self-renewal ability when activated (aVICs) that may contribute to valve repair in
injuries [6]. On the other hand, in calcifying conditions, VICs differentiate into
osteoblastic VICs (obVIC). aVICs display features of myofibroblasts, while obVICs
show characteristics of osteoblasts, or bone-like cells [88, 89]. The calcification of VICs
in the presence of organic phosphate in culture occurs due to the upregulation of alkaline
phosphatase enzyme. VICs also express hydroxyapatite in calcified nodules similar to the
bone formation process [90].
The normal tricuspid aortic valve has two cusps with coronary inlets—left and right
coronary cusps—that are connected to the left and right coronary arteries and are
responsible for the blood supply to the heart muscle. The other cusp with no coronary
inlet is referred as noncoronary cusp. This asymmetric configuration of the tricuspid
aortic valve incurs different blood backflow pressure or possibly localized turbulence on
the coronary and noncoronary cusps during the end diastolic cycle. In CAVD, the
noncoronary cusp is often the first cusp affected with aortic lesions [2], and its stenotic
area is larger than that of the other coronary cusps [91]. While the reason behind this
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difference in calcification is mostly unknown, since VICs are sensitive to their
mechanical environment, the non-uniform

mechanical forces

suggest that a

heterogeneous cell population would exist in these cusps.
The goal of this study is to assess the inherent cellular heterogeneity among the aortic
valve cusps by quantifying VICs’ osteogenic properties in response to biomolecular
factors in culture. We hypothesized that VICs residing in each of the aortic cusps have
intrinsically different characteristics, where VICs isolated from the noncoronary cusp
would calcify more than the coronary cusps.

3.2 Materials and Methods
3.2.1 VIC Isolation and Culture
Aortic valves were removed from freshly sacrificed four to six year old female
porcine hearts obtained from Wampler’s Farm Sausage, Inc., Lenoir City, TN. Each of
the aortic valve cusps were removed, finely chopped, and incubated in collagenase II
digestion solution (15000 U/ml) for 4 hours. The cells were cultured in growth media
consisting of DMEM, 10% FBS, 1% L-glutamine, and 1% Penicillin/Streptomycin (all
purchased from Mediatech, Inc., Manassas, VA) at 37oC and 5% CO2. All cells were
passaged at 90% confluency and used for experiments at 4 passages. VICs were isolated
from four different porcine valves (n=4).
Unless otherwise specified, the VICs isolated from each of the left, right and
noncoronary cusp were seeded onto 6-well plates at a density of 250,000 cells/well.
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Osteogenic media consisted of 2.18 g/L beta-glycerophosphate, 50 mg/L L-ascorbic acid
2-phosphate and 1mM dexamethasone (all purchased from Sigma, St. Louis, MO) added
to regular media. Experimental samples were cultured in osteogenic media, where the
control wells were cultured in regular media.
Culture duration was determined by preliminary studies in which the VICs were
cultured in osteogenic media for different time points ranging from 4 to 20 days. We
noticed the VICs expressed strongest osteogenic markers at day 14, whereas by 20 days,
we observed increased cell monolayer detachment possibly due to cell apoptosis. As a
result, we selected day 14 as the longest calcification duration for this study. Further
experiments were performed at 4, 7, 10, and 14 day time-points.
3.2.2 Hematoxylin & Eosin (H&E) Staining of Tissue Sections
Freshly isolated aortic valve cusps were fixed in 10% formalin, paraffin embedded,
and sectioned using established histology procedure [92]. The tissue sections were
stained with Hematoxylin 2 for 5 minutes and Eosin Y for 1 minute, both purchased from
Richard-Allen Scientific, Kalamazoo, MI. The stained sections were imaged using a
brightfield microscope, and the width of the imaged sections was measured using ImageJ
software (NIH).
3.2.3 DNA Content Quantitation
The cell density for VICs isolated from the coronary and noncoronary cusps were
measured using a DNA assay [92]. Briefly, the cell monolayers were scraped from each
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of the wells of 6-well plate and washed with phosphate buffered saline (PBS) and
digested in Proteinase-K solution (1mg/mL) (Sigma). The cell lysates were vortexed and
then incubated at a temperature between 60oC and 70oC for 90 minutes in a water bath
and then heated at >70oC for 30 minutes to denature the Proteinase-K. Released DNA
was tagged with Hoechst 33258 dye (Sigma) and fluorescence emission was measured
using a BioTek H1 flourocolorimeter at 458 nm. Calf thymus DNA standards (Sigma)
were used in each assay to calculate DNA density.
3.2.4 Von Kossa and Alizarin Red Staining of Cultured VICs
The amount of mineral deposition of cultured VICs isolated from each aortic valve
cusp was determined using Von Kossa staining [30]. The cell monolayers in each well
were fixed in 10% formalin (Fisher Scientific, Fair Lawn, NJ). A silver nitrate (Ricca
Chemical Co., Arlington, TX) solution (3%) was added to the fixed cells, incubated and
then exposed to UV until the calcium salts turned dark brown or black. The undissolved
salts were removed using a 5% sodium thiosulfate (Sigma) solution and dehydrated with
Flex before imaging.
The calcium precipitation and nodule formation of the calcified VICs were assessed
using alizarin red S staining [93]. First, the VICs were fixed with 10% formalin and
treated with alizarin red solutions at room temperature for 4 to 5 minutes. The excess dye
was washed off, and then the VICs were dehydrated with 100% acetone for less than 1
minute. The stained samples were finally imaged at 10X magnification; image analysis
was performed using ImageJ software.
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For image analysis, a number of 30 to 40 images per well were imported into Image
J. The color channel on each image was split, and the threshold was adjusted to form a
black and white image. Finally, the area, area fraction, integrated density, and perimeter
of each image were measured.
3.2.5 Calcium Assay
To measure the calcium content [30], the VICs were homogenized in 1N acetic
acid, and arsenazo dye was added to the samples. The calcium content was measured
against calcium standard (Ricca chemical, Arlington, TX), and the resulting absorbance
was detected at 650 nm using a BioTek H1 plate reader. The calcium content was
normalized to total DNA content.
3.2.6 Alkaline Phosphatase (ALP) Staining and Enzyme Assay
The VICs were stained for ALP using a kit (Sigma) following manufacturer’s
instruction. Briefly, the VICs were fixed with citric acid, 99% methanol and 10%
formalin. The VICs were then incubated in the FRV-alkaline dye and hematoxylin for 15
minutes each. The number of stained cells and total number of cells were counted using
the particles analyzing tool in Image J software.
To measure the ALP enzyme activity [93], the cultured VICs were rinsed with PBS,
then each well was scrapped into 700μL RIPA lysis buffer and sonicated. The ALP
enzyme in the samples was measured against standards prepared from 50 μM pNitrophenol solution. A solution of 221 alkaline buffer (2-Amino-2-methyl-1-propanol,
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1.5mol/L, Sigma) and phosphatase substrate (p-Nitrophenyl phosphate, disodium, Sigma)
was added to the samples and incubated for 30 minutes at 37oC. The reaction was stopped
using 1mM sodium hydroxide solution and the absorbance was measured at 405 nm
using a BioTek H1 plate reader. The ALP amount in each sample was normalized to the
total protein content. The total protein content was determined using Pierce BCA Protein
assay kit (Thermo Scientific).
3.2.7 Glycosaminoglycan (GAG) Content
The VICs and lyophilized aortic valve cusp tissue samples digested in Proteinase-K
solution were used to measure GAG content [30]. Dymethylmethylene blue (DMMB)
dye was added to the samples, and the resulting absorbance was measured at 525 nm. The
total GAG content in each sample was determined against chondroitin sulfate standards
and normalized to total DNA content.
3.2.8 Collagen Content
The collagen type I content was measured using a sirius red assay. The VICs were
digested in proteinase-K, and the lyophilized cusp tissues were digested in pepsin (Fisher
Scientific). The samples were incubated with a sirius red dye (TCI, Portland, OR)
solution (0.3 mg/ml, in 0.5M acetic acid) and then centrifuged at 6000 rpm for 30
minutes. The supernatant was carefully collected from each sample, and the absorbance
was measured at 540 nm using a BioTek H1 plate reader. The collagen content was
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measured against standards prepared from bovine dermal collagen type I (MP
Biomedicals, Solon, OH) and normalized to total DNA content.
3.2.9 Gelatin Zymography
Gelatin zymography was used to determine the amount of matrix metalloproteinase
(MMP)-2, 9 enzyme produced within the cultured cell monolayers [30]. Briefly, equal
amounts (5 mg of protein) of non-reduced samples were loaded into 10% zymogram gels.
After electrophoresis, the gels were shaken in a renaturing buffer for 30 minutes and
cleared overnight in developing buffer at 37oC (Life Technologies, Grand Island, NY).
The gels were then stained using colloidal blue staining kit (Life Technologies) and
destained in 30% ethanol/10% acetic acid for 30 minutes, followed by a rehydration cycle
in 2% acetic acid for at least 15 minutes. The gels were imaged using a Biorad ChemiDoc
XRS imager, and the band densities were calculated using gel analysis tool in Image J
software.
3.2.10 Western Blotting
The cell pellet was collected in a similar manner as described in DNA assay and
digested in RIPA buffer containing protease inhibitor. The protein concentrations were
measured using Pierce BCA protein assay kit (Thermo Scientific). Equal amounts (5 mg
of protein) of samples were run on the acrylamide gels and transferred into nitrocellulose
membranes (A&B biosystems). The protein bands were detected using Runx2 antibody
(Santa Cruz Biotechnology Inc., Santa Cruz, CA) and loading control actin (1-19) (sc35

1616) (Santa Cruz Biotechnology Inc.). The secondary antibody was donkey polyclonal
secondary antibody to rabbit IgG- HPR (ab6802) (Abcam Inc., Cambridge, MA). The
bands were detected using a western blot chemiluminescence detection kit (Fisher
Scientific). The membranes were imaged using a Biorad ChemiDoc XRS imager, and the
band densities were calculated using gel analysis tool in Image J software.
3.2.11 Statistical Analysis
Each experiment was repeated for four different cell isolations (n=4). The most
significant difference was seen after 14 days of culture in almost all of the experiments;
therefore, the plots are presented only for day 14 for the majority of the measurements.
Statistical significance for the different experiments was obtained using single-factor
ANOVA. A p-value of ≤0.05 was considered significant.

3.3 Results
H&E images of healthy porcine aortic valve tissue sections did not show any
visible difference in composition among the three cusps (Fig. 3.1A,B,C). Similarly, no
significant difference was observed in the thickness of the cusps (0.1579, 0.1584, 0.1595
cm for left, right and noncoronary respectively, Table 3.1) measured using Image J
software. Furthermore, no significant difference was observed in collagen and GAG
content among the healthy porcine aortic valve cusps (Fig. 3.1D,E).
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Table 2.1 Tissue section thickness of the porcine aortic cusps
Aortic valve cusp

Left

Right

Noncoronary

Average thickness (cm) n=3

0.1579

0.1584

0.1595

3.3.1 Comparable Cell Density in VICs Isolated from Coronary and
Noncoronary Aortic Cusps
There was no significant difference in DNA content for VICs isolated from the
cusps at the different time points. As shown in Fig.3.2, DNA concentration and fold
change normalized to respective controls was comparable after 14 days of osteogenic
culture for the VICs isolated from each of the aortic cusps.
3.3.2 Elevated Osteogenic Marker Expression in VICs Isolated from
Noncoronary Aortic Cusps
Von Kossa staining of the VICs isolated from all three cusps demonstrated
calcification in the cell monolayers under osteogenic condition compared to respective
controls. The calcified area percentage and integrated density were significantly greater
for the VICs isolated from the noncoronary cusp than for the left or right coronary cusps
after 14 days of culture (Figure 3.3e,f). Furthermore, the amount of calcification
increased with culture duration in osteogenic media in VICs isolated from all aortic
cusps.
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Figure 3.1 H&E staining of paraffin-embedded healthy porcine aortic valve cusp
sections: (A) left, (B) right, and (C) noncoronary cusp. Parts D and E shows collagen and
GAG content for the three cusps measured using a collagen and a GAG assay. No
significant difference was observed in the thickness, collagen, and GAG content among
the cusps. The data represent mean ± std. error, n=3 porcine aortic valves. Scale bar is
250 μm.
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Figure 3.2 DNA content measured using a DNA assay: (A) DNA concentration for VICs
isolated from left, right, and noncoronary aortic cusps at day 14 of culture in regular and
osteogenic media, and (B) fold change for the above VICs in osteogenic culture
normalized to their respective controls. The data represent mean ± std. error, n=4 porcine
aortic valves.
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Figure 3.3 Images of Von Kossa stained VIC samples isolated from (A) left coronary, (B)
right coronary, and (C) noncoronary aortic cusps cultured in osteogenic media for 14
days; scale bar is 250 μm. (D) shows mineral deposition for a representative nodule from
left, right and noncoronary cusps (left to right); scale bar is 100 μm. Image analysis
results show (E) the area fraction and (F) integrated density of mineral deposition in VICs
isolated from each aortic cusp after 4, 7, 10, and 14 days of culture in osteogenic media.
The data represent mean ± std. error, n=4 porcine aortic valves. ⃰ indicates p<0.05
compared to left coronary and # indicates p<0.05 compared to right coronary at the same
time point.
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Alizarin red S staining of the calcific nodules in VIC monolayers demonstrated that
there were differences in the area percentage, integrated density, and size of the calcific
nodules in the VICs isolated from each aortic cusp. The noncoronary and right coronary
cusps showed significantly greater area fraction and nodule size compared to the left
coronary after 14 days of culture in osteogenic condition (Figure 3.4g,h).For integrated
density, the only significant difference was for noncoronary cusp when compared to the
left coronary (Figure 3.4i). Furthermore, the size of the calcific nodules increased with
culture duration for all of the aortic cusps. Not unexpectedly, as the nodules fused with
each other and grew bigger, their number went down in most cases.
The calcium content normalized to respective controls was significantly greater for
VICs isolated from noncoronary aortic cusp than left and right coronary cusps after 14
days of culture in osteogenic condition (Figure 3.5).
ALP staining of the VICs in osteogenic culture showed positive staining from day 7
onwards, and maximum number of ALP positive cells was observed by day 14 (Figure
3.6 A,B). No ALP positive staining was detected in the control wells at any time point. At
day 14, the % ALP positive cell was significantly greater for VICs from noncoronary
cusp than those from either left or right coronary cusp (Figure 3.6C). Similarly, the ALP
enzyme activity increased in all VICs when cultured for longer than 7 days in osteogenic
condition as compared to their respective controls (data not shown). Additionally, the
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Figure 3.4 Nodule formation measured by alizarin red staining in VIC samples isolated
from (A, D) left coronary, (B, E) right coronary, and (C, F) noncoronary aortic cusps
cultured in osteogenic media for 10 and 14 days respectively. Scale bar is 250 μm. Image
analysis results show (G) the nodule area fraction, (H) nodule perimeter, and (I) nodule
integrated density in VICs isolated from each aortic cusp after 4, 7, 10, and 14 days of
culture in osteogenic media. The data represent mean ± std. error, n=4 porcine aortic
valves. ⃰ indicates p<0.05 compared to left coronary and # indicates p<0.05 compared to
right coronary at the same time point.

42

Figure 3.5 Fold change in the calcium, GAG, and collagen I content for VICs isolated
from left, right, and noncoronary cusps normalized to their respective controls at 14 days
of culture in osteogenic media. Noncoronary VICs showed significantly greater calcium,
GAG, and collagen I content compared to the coronary VICs. The data represents mean ±
std. error, n=4 porcine aortic valves. ⃰ indicates p<0.05 compared to left coronary and #
indicates p<0.05 compared to right coronary.

normalized ALP activity was significantly elevated for VICs isolated from noncoronary
cusps with respect to the left and right coronary cusps at day 14 (Figure 3.6D).
Similar to ALP, Runx-2 expression, measured using western blot and normalized to
housekeeping marker β-actin and then to respective controls, was significantly greater in
VICs from the noncoronary cusp than from the coronary cusps after 14 days of culture
(Figure 3.7A,B).
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Figure 3.6 ALP staining and enzyme activity measurement in VICs: (A) Images of ALP
positive VIC samples isolated from left coronary, right coronary, and noncoronary aortic
cusps cultured in osteogenic media for 7,10,14 days; scale bar is 200 μm (B)
Representative image of stained cells for image analysis; scale bar is 50 μm (C) Percent
of ALP/TNAP positive VICs at days 7, 10, and 14 of osteogenic culture. (D) Fold change
in the ALP enzyme activity at day 14 of osteogenic culture normalized to respective
controls. The data represents mean ± std. error, n=4 porcine aortic valves. ⃰ indicates
p<0.05 compared to left coronary and # indicates p<0.05 compared to right coronary.
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Figure 3.7 Runx2 expression in VICs isolated from left, right, and noncoronary aortic
cusps at 14 days of culture. (A) Representative image of bands for Runx2 and β-actin
(control) for VICs isolated from one porcine aortic valve. For each cusp, samples 1 and 2
were cultured in osteogenic media and control was cultured in regular media. (B) Image
analysis of the bands at day 14 of culture. The data represent mean ± std. error, n=2
porcine aortic valves. ⃰ indicates p<0.05 compared to left coronary, ♦ indicates p=0.05
compared to right coronary.
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3.3.3 Elevated Matrix Remodeling in the Calcified Cells
The total GAG content normalized to respective controls was significantly greater
for VICs isolated from noncoronary aortic cusp than left and right coronary cusps after 14
days of culture in osteogenic condition (Figure 3.5). The difference in normalized GAG
content was greatest at day 14 than for earlier time points for the noncoronary cusp as
compared to the coronary cusps (data not shown for earlier time points). Similarly,
collagen I content normalized to respective controls at day 14 was significantly greater
for the noncoronary cusp as compared to the coronary cusps.
Gelatin zymography showed that VICs in both osteogenic and regular media
expressed inactive (pro) MMP-2; however, activated MMP-2 was observed only in VICs
cultured in osteogenic condition. Figure 3.8A shows a representative image of the active
(bottom white lines) and inactive (top lines) MMP-2. Image analysis of the bands showed
that the VICs isolated from noncoronary aortic cusps demonstrated significantly elevated
amount of active MMP-2 enzyme as compared to the right coronary cusp; however,
active MMP-2 amount in the noncoronary cusps was not significantly elevated when
compared to the left coronary cusp (Figure 3.8B). Similarly, no significant difference was
obtained for the inactive and total MMP-2 content among the VICs from any of the
groups. The bands for MMP-9 were not detectable in this study.
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Figure 3.8 MMP-2 expression (active, inactive, total) detected by gelatin
zymography for VICs isolated from left, right, and noncoronary at 14 days of culture. (A)
Representative gel image for VICs isolated from left, right, and noncoronary cusps from
the same porcine aortic valve. (B) Image analysis of the bands for VICs isolated from
each aortic cusp at day 14 of culture. The data represent mean ± std. deviation, n=4
porcine aortic valves. # indicates P<0.05 compared to right coronary.
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3.4 Discussion
In the present work, we observed a correlation between the location of the VICs
within aortic valve cusps and the events associated with the initiation of calcification
when cultured in pathological conditions. There was no significant difference in tissue
thickness, collagen, and GAG content among the three cusps of healthy porcine aortic
valves used for VIC isolation. The primary outcomes of this research are that VICs
isolated from the noncoronary aortic cusp expressed a greater amount of calcific markers
(ALP), osteogenic differentiation (Runx2), and mineralization when compared to left and
right coronary cusps after 14 days of culture in osteogenic condition. Moreover, no
significant difference in the normalized DNA content was noticed among the VICs,
inferring that the observed difference in calcific markers and mineralization among the
cusps was not due to a larger cell density. Our results suggest that there might be an
inherent difference in VICs’ characteristics isolated from noncoronary and coronary
cusps that initiates calcification earlier than other cell population.
Numerous reports suggest that the noncoronary cusp is affected first during CAVD.
The difference in calcification among aortic cusps has been studied clinically using
echocardiography [94, 95] or CT imaging [26, 96] on stenotic patients. It was reported
that the location of noncoronary cusp commissure correlates to the highest pressure
overload or calcium deposition. An attempt to detect difference in early-stage
calcification between the coronary and noncoronary cusps has been performed by Cujec
and Pollick [95]. They reported that isolated thickening of a single aortic cusp was
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frequently seen in the noncoronary cusp and rarely seen in the left coronary cusp. In
another work, the calcified aortic cusps were weighted separately in valve transplantation
patients, and the most frequent case reported was that one cusp was heavier with the other
two having similar weights. However, they did not clarify which cusp had more weight
[97]. Recently, a new study measured the calcific volume using the CT method in
severely calcified cusps and showed that on average, the noncoronary cusps had greater
volume of calcification than the left and right coronary cusps [96].
Ectopic aortic calcification is associated with expression of osteogenic and matrix
remodeling markers. In pathological conditions, VICs form osteogenic nodules with
increased mineralization and ALP enzyme activity [31, 90, 98]. Our study showed that
the area covered and average size of the calcific nodules were not similar for VICs
isolated from all cusps—the noncoronary VICs demonstrated the greatest % area and
perimeter of nodules. Similarly, the integrated density analysis of the nodules
demonstrated the greatest mineralization in noncoronary cusps. To support these
observations, the calcium content was greatest for the VICs from noncoronary cusp by 14
days of osteogenic culture. Aortic calcification is associated with bone formation via
osteogenesis [99]. The VICs under osteogenic culture condition differentiated into
osteoblast-like cells [6], as is found in human calcified aortic valve tissues [100]. Since
calcific nodules contain osteoblast-like VICs, it can be inferred that noncoronary cusps
has an elevated number of differentiated VICs and a propensity for active bone
formation. Osteogenic nodule formation is marked with significant amount of ALP
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enzyme within the calcific deposits [13]. In our study, we observed that the amount of
ALP and percent ALP positive cells were significantly greater in noncoronary VICs than
in the left and right coronary cusps by day 14 of culture. Likewise, Runx-2 expression
was significantly enhanced in VICs from noncoronary than for coronary cusps at 14 days
of culture, suggesting osteoblast-like differentiation is ongoing at different levels in the
VICs. Interestingly, we noticed positive Runx-2 band in a few of the control western blot
samples, even though the control samples did not stain positive in von kossa or alizarin
red. Since VICs have been reported to spontaneously calcify [101, 102], it is possible that
some of the VICs in control samples were also undergoing osteogenic differentiation.
Calcific aortic valves show major ECM remodeling and abnormal activation of
MMPs, a family of zinc-containing matrix enzymes that cleave various ECM
components. An abundance of active MMP-2 enzyme among VICs is an early marker of
matrix remodeling in aortic valve cusps [13, 103]. In our study, increased collagen I was
synthesized by noncoronary VICs in osteogenic culture compared with left and right
coronary. Furthermore, we observed a trend of increased active MMP-2 in VICs isolated
from the noncoronary cusps in osteogenic culture after 14 days compared to left and right
coronary cusps, indicating elevated matrix remodeling in noncoronary cusps. However,
the trend for total active and inactive MMP-2 was not consistent, and no significance was
noted among the groups. It might be that a longer culture or greater cell density, which
was not selected in this study due to increased apoptosis, is needed to obtain a stronger
difference in MMP-2 enzyme expression for the VICs. It should be noted that other
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MMPs, such as MMP-1, 9, and 13 have been detected in diseased valve tissues [104], but
only MMP-2 was detected in the VICs in this study. Our results are consistent with the
literature since majority of VIC calcification studies measured only MMP-2 enzyme
expression in VICs [103, 105, 106]. In fact, MMP-2 is the predominant ECM degrading
enzyme expressed by VICs under most conditions [7], and expression of other MMPs in
VICs in culture often requires their isolation from diseased tissues [107] or stimulation by
growth factors and cytokines. Since no growth factor or cytokines were used in the
osteogenic media, we could only detect the heavily expressed MMP-2 in this study. ECM
remodeling is also associated with excessive synthesis of ECM proteins like GAGs [108].
Our results also showed increased GAG amount in noncoronary VICs compared with left
and right coronary, confirming excessive matrix synthesis in the noncoronary cusp.
VICs’ have been identified as a heterogeneous population in numerous cell culture
and tissue-based studies. The mesenchymal progenitor VICs subpopulation has the ability
to differentiate into osteoblast- or myofibroblast-like cells based on environmental cues
or local mechanical stimuli [6]. In the present study, we showed for the first time that the
osteogenic marker expression of the VICs and their ECM remodeling differ among the
coronary and noncoronary aortic cusps. Heterogeneity of VICs according to their location
within the aortic valve has been reported previously showing that VICs from fibrosa
layer demonstrated increased matrix remodeling and osteogenic markers compared to the
ventricularis layers [108-113]. It was suggested that this is due to the different levels of
cellular level strain experienced by VICs residing in each side of the cusp. VIC
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phenotype analysis further showed that VICs in the fibrosa layer have a higher tendency
to appear as myofibroblast- or osteoblast-like cells. On the other hand, VICs from the
ventricularis layer showed greater potential for myofibroblast differentiation than those
from the fibrosa layer in response to profibrotic stimuli in vitro suggesting that fibrosa
VICs are inherently less sensitive to profibrotic signals [11]. Based on the present study,
VICs from coronary cusps are inherently less responsive to osteogenic condition than
noncoronary VICs.
This study was limited by the fact that only early calcification markers, such as ALP
and Runx2, could be detected in the osteogenic cultures. Since we chose not to use any
calcification enhancing growth factors and cytokines, such as TGF-β, bone morphogenic
proteins (BMPs), tumor necrosis factors (TNF)-α in our osteogenic media, a culture of
minimum 21 days [31, 114] would likely be required to detect late calcification markers
(osteocalcin, osteopontin etc.). Unfortunately, we had to limit our culture to 14 days to
avoid excessive apoptosis in the VICs. This study also opens up questions regarding size
of different cell population within each cusp. In addition to the local difference in
mechanical forces due to the coronary inlets and mitral backflow, the embryonic origin of
aortic valve cusps could predispose these VICs differently to calcification. For example,
cardiac neural crest cells (NCC) are uniquely distributed within the aortic valve during
development, where majority of NCCs are present in left and noncoronary cusp [115].
Additionally, selective knockout of certain NCC markers reportedly results in abnormal
aortic valve formation similar to bicuspid aortic valves [116]. It is possible that due their
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embryonic origin, VICs from the left and noncoronary cusp will have elevated response
to procalcific conditions than the right cusp. Unfortunately, the measurements reported in
this study did not show any consistent trend between the left and right cusp. Further
investigation is thus needed to discern the relationship between the VICs propensity
towards osteogenic differentiation and the contributions of cellular embryonic origin and
local mechanical stimuli.

3.5 Conclusion
In this study, we report a difference in the initiation of calcification of the VICs
isolated from the coronary or noncoronary cusps. VICs isolated from noncoronary aortic
cusps expressed elevated amount of osteogenic markers and greater matrix remodeling
than VICs isolated from left and right coronary cusps. We also observed a positive
correlation between the duration of osteogenic culture and calcification of the isolated
VICs for all three aortic cusps. Furthermore, the above differences among the VICs were
not due to an increased cell density in culture. Our results suggest that the VICs
distributed among all three aortic valve cusps might be inherently different, or that a
subpopulation of VICs predisposed to calcification might be present at varying density
among the cusps. Further investigation is required to characterize the VICs’ different subphenotypes throughout the aortic valve and to determine the role of local mechanical
stimuli and cellular embryonic origin on VIC differentiation.
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CHAPTER FOUR
SEX-RELATED DIFFERENCES IN MATRIX
REMODELING AND EARLY CALCIFIC MARKERS IN
RAT AORTIC VALVULAR INTERSTITIAL CELLS
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A version of this chapter is to be published as:
Masjedi S, Lei Y, Ferdous Z. Sex-related differences in matrix remodeling and
early calcific markers in rat aortic valvular interstitial cells, in preparation.

Abstract:
Calcific Aortic Valve Disease (CAVD) is a major cardiovascular disorder in the
developed countries. Male is a known risk factor in this disease; unfortunately, how sex
contributes to CAVD is mostly unknown.
The objective of this study was to determine whether valvular interstitial cells
(VICs) isolated from male versus female aortic valves demonstrate difference in
calcification and/or extracellular matrix (ECM) remodeling.
VICs were isolated from male and female rat aortic valves and cultured in
osteogenic media for 10, 15 and 20 days. The proliferation among male and female VICs
was assessed by a cell growth assay. The matrix remodeling of the VIC samples was
quantified using glycosaminoglycan (GAG), collagen type I and gelatin zymography
assays. Early calcific marker expression was assessed using alkaline phosphatase (ALP)
staining and enzyme activity assay. Our result showed that proliferation of VICs was
significantly greater in female than male after 12 days of culture in regular media.
Additionally, male VICs showed greater amount of normalized GAG, collagen I, and
activated matrix metallopreoteniase-2 expression compared to female. Similarly, ALP
content was greater in male VICs than female at all time points.
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The results from this research suggest that there is sex-related difference in the
events associated with osteogenic differentiation of the aortic VICs, where male VICs are
more prone to calcification.
Keywords: Calcific aortic valve disease, valvular interstitial cells, sex-related
differences, osteogenic differentiation

4.1 Introduction
Aortic valve stenosis is the most common cause of valve replacement surgery in the
US [12] and occurs at the advanced stage of calcific aortic valve disease (CAVD). CAVD
is an active cell-mediated disorder mostly caused by ectopic calcification in the aortic
valves [15]. Unfortunately, the underlying mechanisms of initiation and progression of
CAVD are not fully understood. Furthermore, since sex is a major risk factor for CAVD,
there is an urgency for a better understanding of this diseases’ pathology and role of key
risk factors.
Male sex has been identified as an independent risk factor for CAVD. Clinical
reports have shown that male gender has two fold excess risk of aortic valve calcification
[82]. Similarly, based on the Society of Thoracic Surgery risk scores, men have 19%
higher relative rate of undergoing aortic valve replacement surgery due to aortic valve
stenosis than women [117]. Several population-based studies highlighted differences in
aortic valve calcification between male and female indirectly by concentrating on left
ventricular hypertrophy due to pressure overload caused by aortic valve stenosis [11856

121]. Furthermore, men appear to have more aortic valve calcium score and fibrosis
thickening compared to women with aortic valve stenosis measured by ComputerTomography [38, 122]. Analysis of the longitudinal sections of the aortic valves in aged
mice showed significantly thicker leaflets and higher degree of aortic regurgitation in
male mice compared to female [123]. The impact of sex on pathogenesis and progression
of aortic valve stenosis at cellular and molecular levels thus needs to be investigated.
Aortic valve calcification involves various mechanisms to interact with the residing
cells within the aortic valve. There are two main cell types in the aortic valve: valvular
endothelial cells (VECs), a cellular monolayer lining the outer surface of the valve cusps;
and valvular interstitial cells (VICs), the dominant valve cell population that are
distributed heterogeneously within the interstitial matrix [7]. At the initial stage of
calcification, inflammation occurs due to VEC activation which triggers the extracellular
matrix (ECM) remodeling and VIC differentiation. This is followed by expression of
calcific markers such as alkaline phosphatase (ALP), Runx2, osteocalcin, and
osteopontin, change in ECM proteins and enzymes such as glycosaminoglycan (GAGs)
and matrix metalloproteinases (MMPs). The abnormal amount of calcific deposition
within the ECM results in tissue stiffness and nodule formation as seen in stenotic valves.
The role of sex/gender on non-valvular cardiovascular diseases has been contributed to
the sex steroid hormones- mainly estrogen- and their receptors in the cardiovascular cells.
β-Estradiol, the natural form of estrogen in human, was shown to have a protective effect
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in women in heart valve diseases. Molecular mechanism of β-Estradiol contribution to
VICs’ fate still remains unknown.
In this study, we investigated whether the rat aortic valvular interstitial cells VICs
isolated from male and female rat aortic valves show differences in matrix remodeling
and early calcific markers when exposed to osteogenic culture conditions. We also
assessed the VICs proliferation in the presence of β-Estradiol. We hypothesized that
VICs isolated from each of the sexes would demonstrate different characteristics, where
male VICs would demonstrate greater matrix remodeling and calcification compared to
female VICs.

4.2 Materials and methods
4.2.1 Primary VIC isolation and culture
Rat aortic valvular interstitial cells (RAVICs) were isolated and cultured from the
aortic valves of freshly sacrificed 9-week-old male and female Sprague-Dawley rats
(Envigo, formerly Harlan laboratory, Indianapolis, IN) using explant technique [17].
Briefly, the aortic valves were gently cut into 4-5 pieces and placed into a T25 culture
plate and covered with a growth media consisting of DMEM, 10% FBS, 1% L-glutamine,
and 1% Penicillin/Streptomycin (all purchased from Mediatech, Inc., Manassas, VA).
The culture plates were then placed in cell culture incubators at 37oC and 5% CO2. At
50% confluency, the valve pieces were removed, and the RAVICs were split into T75
culture dishes . All cells were passaged at 90% confluency and used for experiments
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between 6-7 passages. RAVICs were isolated from four different pairs of rat valves (n=4
for each sex).
Unless otherwise specified, the male and female RAVICs were seeded onto 6-well
plates at a density of 250,000 cells/well. Osteogenic media consisted of 2.18 g/L betaglycerophosphate, 50 mg/L L-ascorbic acid 2-phosphate and 1mM dexamethasone (all
purchased from Sigma) added to regular media. Experimental samples were cultured in
osteogenic media, where the control wells were cultured in regular media. Culture
duration was determined by preliminary studies where the RAVICs were cultured in
osteogenic media for different time points ranging from 10 to 25 days. We noticed the
RAVICs expressed strongest osteogenic markers at day 15 whereas by 21 days, we
observed increased cell monolayer detachment possibly due to cell apoptosis. As a result,
we selected day 20 as the longest calcification duration for this study. Further
experiments were performed at 10, 15 and 20 day time-points.
4.2.2 DNA content
A colorimetric DNA assay was used to quantify the cell density of the male and
female RAVICs [124]. Briefly, the cell pellets were digested in Proteinase-K solution
(1mg/mL) (Sigma), followed by incubation of the cell lysates at a temperature between
60oC and 70oC for 90 minutes in a water bath and then heating at >70oC for 30 minutes to
denature the Proteinase-K. Hoechst 33258 dye (Sigma) was used to tag the released
DNA. The fluorescence emission was measured using a BioTek H1 Fluoro-colorimeter at
458 nm. Calf thymus DNA standards (Sigma) were used to calculate the DNA density.
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4.2.3 Cell growth assay
The rates of RAVICs growth for each sex were quantitatively determined as
previously described [125]. Briefly, male and female RAVICs were seeded in separate
12-well plates at a density of 10,000 cells/well and cultured for up to14 days in both
regular and osteogenic culture media. The media was changed every 2 days. Every 2
days, the cell populations were counted from triplicate wells using a hemocytometer
(trypan blue exclusion).
4.2.4 GAG content
The GAG content was measured by adding a solution of Dymethylmethylene blue
(DMMB) dye (Sigma) to the male and female RAVICs samples digested in Proteinase-K
solution. The resulting absorbance was measured at 525 nm using a BioTeck H1 plate
reader. The total GAG content in each sample was determined against chondroitin sulfate
standards and normalized to total DNA content.
4.2.5 Collagen type I content
The collagen type I content was measured using a sirius red assay. The ProteinaseK digested RAVICs samples were incubated with a sirius red dye (TCI) solution (0.3
mg/ml, in 0.5M acetic acid) and then the supernatant was carefully collected from each
sample after centrifugation at 6000 rpm for 30 minutes. The absorbance was measured at
540 nm using a BioTek H1 plate reader. The collagen standards were prepared using
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bovine dermal collagen type I (MP Biomedicals). The total collagen type I content was
normalized to total DNA content.
4.2.6 Gelatin zymography
The amount of matrix metalloproteinase (MMP)-2, 9 enzyme produced by the
RAVICs from each sex was determined using gelatin zymography. Briefly, equal
amounts (5 mg of protein) of samples were ran through 10% zymogram gels, then
renatured for 30 minutes and rinsed overnight in developing buffer at 37oC

(Life

Technologies, Grand Island, NY). A colloidal blue staining kit (Life Technologies) was
used to stain the gels followed by destaining in 30% ethanol/10% acetic acid for 10
minutes and rehydration in 2% acetic acid for at least 15 minutes. The gels were imaged
using a Bio-Rad ChemiDoc XRS imager, and the band densities were determined using
Image J software.
4.2.7 ALP staining and enzyme activity
For ALP staining, the male and female RAVICs were fixed by a previously
optimized mixture of citric acid, methanol and formalin [124]. Next, the fixed cell
monolayers were stained with FRV-alkaline dye according to manufacturer’s protocol
(Sigma 86R kit), followed by counter staining with diluted hematoxylin (1:1). The
percentage of positively stained and total cells were calculated using the particles
analyzing tool in Image J software.
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To measure the ALP enzyme activity, the cultured RAVICs were homogenized in
RIPA lysis buffer. 50 μM p-Nitrophenol solution (Sigma) was used to prepare standards.
The samples were incubated with alkaline buffer (2-Amino-2-methyl-1-propanol,
1.5mol/L, Sigma) and phosphatase substrate (p-Nitrophenyl phosphate, disodium, Sigma)
for 30 minutes at 37oC. The reaction was stopped using 1mM sodium hydroxide solution,
and the absorbance was measured at 405 nm using a BioTek H1 plate reader. The ALP
amount in each sample was normalized to the total protein content determined using
Pierce BCA Protein assay kit (Thermo Scientific)
4.2.8 β-Estradiol treatment
The male and female RAVICs were seeded separately in 12-well culture plates at a
density of 10,000 cells/well and cultured in regular media prepared with phenol red-free
DMEM (Life Technologies) for 24 hours. Next, the VICs were made quiescent by serum
starvation for 48 hours in the above mentioned media without FBS. Lastly, the VICs were
treated with media supplemented with different concentrations of β-Estradiol (0-40
ng/ml) (Sigma) for 48hours. The cell numbers were counted in triplicate for each
concentration of β-Estradiol by trypan blue exclusion using a hemocytometer.
4.2.9 Statistical analysis
Each experiment was repeated for three different cell isolations from each pair of
rats (n=4). Statistical significance for the different experiments was obtained using
single-factor ANOVA. A p-value of ≤0.05 was considered significant.
62

4.3 Results
4.3.1 Comparable cell density between male and female RAVICs
The DNA content of the cell lysates is an indicator of the cellular density. For each
sex, there was no significant difference in the DNA content between calcified VICs in
osteogenic media and their respective controls cultured in regular media for all time
points (Figure 4.1 A and B for male and female VICs, respectively). Likewise, the DNA
fold change of the RAVICs normalized to their respective controls was comparable
among male and female for all time points (Figure 4.1C).
4.3.2 Greater proliferation in female RAVICs compared to male
Visual comparison of the VICs’ proliferation indicated similar confluency at the
initial stage of culture (day 2) in female and male cells; however, after 12 days of regular
culture female cells showed more confluency (Figure 4.2A). The cell growth
measurements in regular and osteogenic media showed that osteogenic condition reduced
cell growth for both male and female RAVICs as compared to regular media over time.
Furthermore, female RAVICs showed significantly greater proliferation at 12 days in
regular media as compared to male. No significant difference was seen among male and
female RAVICs in osteogenic media (Figure 4.2B).
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Figure 4.1 DNA content of VICs isolated from (A) male and (B) female rat aortic valves
after 10, 15 and 20 days of culture in regular and osteogenic media. (C) comparison of
DNA fold change for VICs cultured in osteogenic media normalized to their respective
controls among male and female at all time points. Data represents mean ± std.error, n=4
rat pairs.
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Figure 4.2 (A) representative images of female and male VICs cultured for 2 and 12 days
in regular media. Scale bar is 250μm. (B) Number of cells measured every 2 day for
female and male VICs in both regular and osteogenic media with day 0 being the first day
of osteogenic culture. The data represent mean ± std.error, n=2 rat pairs, *P < 0.05
compared to male VICs in regular media at the same time point.
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4.3.3 Elevated matrix remodeling in calcified male RAVICs compared with
female
The male RAVICs demonstrated significantly greater amount of total GAG content
when normalized to their respective controls as compared with female after 10 and 15
days of culture in osteogenic media. No significance was observed after 20 days of
osteogenic culture although a difference was noticed (Figure 4.3A). The collagen type I
content normalized to respective controls was significantly greater in male VICs than
female at 15 days of culture in osteogenic media (Figure 4.3B).
Evaluation of MMPs by gelatin zymography showed that VICs cultured in both
regular and osteogenic media expressed pro-MMP-2 (inactive). Activated MMP-2,
however, was present only in VICs cultured in osteogenic media. Expressed MMP-2
bands for VICs isolated from male and female rat aortic valves after 15 days of culture is
shown in Figure 4.4A, where top white lines correspond to pro-MMP-2 and bottom white
lines to active MMP-2. After image analysis of the bands and normalizing to their
respective controls, the amount of activated MMP-2 in male RAVICs was significantly
elevated compared to female after 15 days of culture in osteogenic media (Figure 4.4B).
However, no significance was seen in the inactive and total MMP-2 amounts between
male and female VICs cultured in osteogenic media for 15 days. Similarly, no
significance was seen in the active, inactive and total MMP-2 contents at 10 and 20 days
of culture between male and female VICs (data not shown). MMP-9 bands were not
detectable in this study.
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Figure 4.3 Fold change in (A) GAG and (B) collagen type I content for VICs isolated
from male and female rat aortic valves normalized to their respective controls after 10, 15
and 20 days of osteogenic culture. The data represent mean ± std.error, n=4 rat pairs for
GAG, n=3 rat pairs for collagen I, *P < 0.05 and P=0.07 compared to female VICs at the
same time point.
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Figure 4.4 MMP-2 expression in VICs isolated from male and female rat aortic
valves after 15 days of culture; (A) representative gel image of control and calcified
VICs, and (B) MMP-2 fold change (inactive, active, total) of VICs cultured in osteogenic
media normalized to their respective controls. The data represent mean ± std.error, n=2
rat pairs, *P < 0.05 compared to female VICs at day 15.

68

4.3.4 Elevated early calcific marker expression in male RAVICs as compared
to female
ALP staining of the VICs cultured in osteogenic condition showed that female cells
did not stain positive for ALP at day 10 (Figure 4.5A); however, after 15 and 20 days of
culture, the number of positive stained female cells increased (Figure 4.5B,C). On the
other hand, male VICs stained positive at all time points (Figure 4.5D, E, F). The image
analysis of ALP positive cells showed that the maximum percentage of positive stained
cells occurred at day 15 of osteogenic culture for male VICs. Furthermore, the % ALP
positive cells were significantly greater for male VICs than female at all time points
(Figure 4.5G). The control VICs did not stain positive for ALP. Similarly, ALP enzyme
activity measurement showed significantly greater amounts of ALP enzyme in male VICs
in osteogenic media normalized to respective controls compared to female VICs at all
time points; although the difference in ALP enzyme activity between male and female
VICs was largest at day 10 of osteogenic culture (Figure 4.5H).
4.3.5 Diminished proliferation of the female VICs due to β-Estradiol treatment
Images of RAVICs showed that for both male and female, less cell growth was
noticeable when β-Estradiol was added to the media after 2 days (Figure 4.6A). The cell
number of female RAVICs decreased when treated with β-Estradiol for 2 days, and cell
number decreased further in more concentrated β-Estradiol media. However, male
RAVICs proliferation rate was not influenced by β-Estradiol (Figure 4.6B).
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Figure 4.5 ALP expression measurements in female and male VICs after 10 (A,B), 15
(C,D) and 20 (E,F) days of culture in osteogenic media. Scale bar is 100 μm (G) Image
analysis show percent of ALP positive male and female VICs for day 10, 15 and 20, (H)
Fold change in ALP enzyme activity of RAVICs cultured in osteogenic media for 10, 15
and 20 days normalized to their respective controls measured by absorbance. The data
represent mean ± std.error, n=2 rat pairs, *P < 0.05 compared to female RAVICs at the
same time point.
70

Figure 4.6 (A) Images of male and female VICs treated with 0 and 20 ng/ml β-Estradiol
in regular culture media for 2 days. Scale bar is 250μm. (B) number of male and female
VICs treated with different concentrations of β-Estradiol ranging from 0 to 40 ng/ml for 2
days. The data represent mean ± std.error, n=2 rat pairs.
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4.4 Discussion
In the present study, we showed that sex-related differences exist in the events
associated with the osteogenic differentiation of VICs cultured in pathological condition.
The highlights of this research are that VICs isolated from male aortic valves
demonstrated greater amounts of matrix remodeling proteins (MMP-2) and excessive
matrix synthesis (GAG, collagen I) after 15 days of culture in osteogenic media
compared to female. Similarly, male VICs showed significantly elevated early calcific
marker expression (ALP) compared to female VICs when cultured in osteogenic
condition for 10, 15 and 20 days. Moreover, VICs isolated from female aortic valves
showed greater proliferation than male when cultured for 12 days in regular media.
Osteogenic culture condition seems to hinder proliferation for both male and female
VICs. No significant difference was observed in DNA content of VICs cultured in
osteogenic vs. regular media and male vs. female for each time point. This indicates that
the observed differences in matrix remolding and calcific marker expression between the
male and female aortic valves are not due to larger cell population. These results suggest
that cellular-level differences among male and female VICs exist and may contribute to
the excess risk of aortic valve calcification in male.
It is well accepted that male is a significant risk factor for CAVD. Calcium deposits
within the stenotic aortic cusps have been measured by computer-tomography calcium
scoring, showing that men have greater aortic valve calcification score than women with
similar aortic stenosis severity [38, 122]. This may be related to the more adaptive left
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ventricular response in women to the hypertrophy caused by aortic stenosis, which is an
index for measuring the severity of aortic stenosis [32]. Similarly, calcium volume of the
stenotic aortic valves was greater in aged men than women patients [126]. A study on the
influence of sex on pathological changes performed on ApoE Knock-out aged mice
reported increased thickness, acellularity, GAG transformation and fibrosis of the
spongiosa layer in male aortic leaflets compared to aged female mice; however, no
valvular calcification in ApoE or wildtype mice was observed [123]. Another work on
genetic evaluation of the sex-related differences in aortic valves has identified 183 genes
to be significantly different among male and female VICs isolated from healthy porcine
aortic valves, where few of these genes contribute to the pathways associated with CAVD
[39]. Our study, for the first time, showed that there are sex-related differences in early
osteogenic differentiation of the aortic valves at the cellular level.
In a normal aortic valve cusp, majority of VICs are a quiescent sub-phenotype of
fibroblasts [11, 127]. A small population of mesenchymal progenitor VICs exists with
differentiation capability into myofibroblasts or osteoblast-like cells. In aortic valve
injuries, the mesenchymal progenitor VICs become activated and proliferate to repair the
valve [6, 7]. Our results show that in regular culture condition, female RAVICs
proliferate faster than male. It can be inferred that male VICs are inherently less prone to
proliferation. Previous studies associated VICs’ proliferation to aortic valve calcification;
however, VICs used in these studies were isolated from stenotic or aged patients [128], or
cytokines like Interleukin-1 beta (IL-1β) [129] were added to the VICs. Our results
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confirmed that osteogenic culture inhibited VICs’ proliferation regardless of the sex of
the cells.
Matrix remodeling, excessive ECM protein synthesis and calcific markers
expression are hallmarks of calcific aortic valves. MMP-2 is the major matrix degrading
enzyme that is abundantly expressed among calcified VICs [13]. In our study, VICs
isolated from male rat aortic valves showed significantly elevated expression of activated
MMP-2 compared to female after 15 days of culture in osteogenic media. However, the
amounts of inactive and total MMP-2 among male and female VICs were comparable.
Furthermore, longer osteogenic culture duration of 20 days did not show significant
difference in any type of MMP-2 (active, inactive, total) among male and female VICs
possibly due to apoptosis. Larger cell density might be required to obtain greater
difference in MMP-2 expression among male and female VICs. In calcific valves, matrix
deposition and fibrosis have also been reported where activated VICs produce excessive
collagen I, proteoglycans and other matrix proteins [130]. Our results showed greater
amounts of normalized GAG and collagen I contents in male RAVICs compared to
female cultured in osteogenic media, indicating elevated matrix remodeling in activated
male RAVICs.
Osteogenic differentiation of aortic VICs is associated with calcific marker
upregulation. ALP is often detected in VICs isolated from diseased aortic valves [14] or,
when cultured in pathological conditions [124]. Our study showed that amounts of ALP
enzyme and percent ALP positive cells were significantly greater in VICs isolated from
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male rat aortic valves than female for all time points of osteogenic culture. This suggests
that male VICs might be more prone to osteogenic differentiation in pathological
condition.
At the cellular level, every cell in the body has a sex due to chromosomal
complements that define the sex. Estrogen Receptors (ERs) subtypes are a member of
intracellular receptor family known as the nuclear ligand-activated transcription factors.
ER-α and -β and GPER (G-protein coupled estrogen receptor) located on the plasma
membrane are present in both human vascular smooth muscle cells [131, 132] and
endothelial cells [133, 134]. Through binding to ERs, the natural estrogen β-Estradiol
demonstrated regulatory effects in the vascular cells, as previously reviewed [135].
Examples include rapid generation of Nitric Oxide (NO) in the endothelial cells that has
anti-inflammatory and vasodilatory effects in vasculature [136], or modulation of Ca2+
ion channel mobilization on smooth muscle cells [137]. Sex-related differences of
cultured vascular smooth muscle cells have been studied in response to NO exposure [68]
or UV radiation to stimulate atherosclerotic condition [138]; likewise, sex-related
differences in their ability of ECM production and remodeling and proliferation have
been tested when treated with β-Estradiol [139]. In this study, we measured sex-related
difference of β-Estradiol treatment on RAVICs. Our results showed that β-Estradiol
decreased the cell proliferation in female RAVICs indicating an inhibitory effect on
female VICs proliferation. However, β-Estradiol appeared to have no effect on male
VICs proliferation.
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Limitations of this study include VICs from aged rats were not used for sex-related
difference assessment. In fact, we isolated VICs from aged male and female rats
(Appendix, Figure Ap.3A,B); however, we were not able to grow the aged cells to a large
population possibly due to low proliferation ability of the older cells and the small size of
the aortic valve in a rat heart. Coating of the culture plates with gelatin or collagen I and
using growth factors are potential solutions that we did not use in this study to be
coherent with the results from young VICs; however, can be used for future
investigations. Another limitation is the inability to detect late calcific markers. A larger
cell density or adding of a calcification promoter like Tgf-β might be required to obtain
late calcific markers. Unfortunately, we did not use lager cell density or growth factors to
avoid apoptosis. Furthermore, no nodule formation or mineralization was observed within
both male or female VICs at all times of osteogenic culture. The latter opens up
possibilities for comparative studies on calcification among different species. Another
limitation is that we did not test the effect of other hormones like dihydrotestosterone or a
cocktail of hormones on VICs. Unfortunately, our laboratory has limitations regarding
use of certain hormones like dihydrotestosterone.

4.4 Conclusion
In this study, we report sex-related differences among VICs isolated from male
versus female rat aortic valves in the events associated with osteogenic differentiation.
Male VICs demonstrated greater matrix remodeling and elevated amounts of early
calcific markers than female VICs when cultured in pathological condition. The above
76

differences were not due to differences in cell density among male and female. We also
observed an inhibitory effect of β-Estradiol on female VICs proliferation only. Our
results suggest that there is cellular differences within the male and female aortic valves.
A subpopulation of VICs that is predisposed to osteogenic differentiation might exist at
varying density within male and female aortic valves that causes these differences, or the
density of estrogen receptors in male and female VICs might be inherently different.
Further investigations are required to assess the VICs inherent characteristics or to
quantify different subpopulations within male and female aortic valves.
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CHAPTER FIVE
CALCIFICATION POTENTIAL OF AORTIC VALVULAR
INTERSTITIAL CELLS UNDER CYCLIC STRAIN
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In chapter 3, I presented a comparative study on calcification of the VICs isolated
separately from coronary and noncoronary cusps of porcine aortic valves. I found that
VICs isolated from noncoronary cusps demonstrate greater calcification potential
compared to coronary cusps. In chapter 4, I investigated the sex-related differences in
osteogenic differentiation among VICs isolated from male and female rat aortic valves. I
identified that male VICs represent greater ECM remodeling and early calcification than
female. In the present chapter, I tested both hypotheses under cyclic strain to verify
whether the VICs’ calcification will be enhanced between male and female or among
different aortic cusps.
For evaluation the male and female RAVICs’ calcification under cyclic strain, I
have primary contribution to all the steps of designing and performing the experiments,
analyzing the results, and writing the manuscript. In the second part for testing PAVICs’
calcification from different aortic cusps under cyclic stretch, the experiments were
performed in collaboration with another graduate student from our lab.

5.1 Introduction
Aortic valve disease is a major cardiovascular disorder that affects approximately
28% of the elderly population. It has been well established that male sex is a risk factor
for aortic valve disease [140]. However, the underlying mechanism relating male sex to
increased aortic valve calcification remains unclear. In addition to sex, several studies
have shown a direct relationship between hypertension and aortic valve disease.
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It has been shown that normal aortic valves constantly interact with the enforced
mechanical forces in each systolic cycle. The inhabitant aortic VICs characteristics vary
due to hemodynamic changes. Previous studies on tissue [110, 141] or cultured VICs [30]
have shown that cyclic strain contribute to the VIC differentiation and remodeling; where
at abnormal levels VICs demonstrate elevated calcification.
In the present study, we aim to determine if the aortic VICs isolated from male and
female rats develop different amounts of calcification when cultured under representative
physiological (10%) or pathological (15%) levels of cyclic strain. Additionally, we will
test whether VICs isolated from different aortic cusps of porcine valves demonstrate
different amount of calcification under cyclic strain in osteogenic media. The results from
this study would provide crucial information at cellular level to understand if the VICs
isolated from different sex or aortic cusps demonstrate different amounts of calcification
under cyclic stretching.

5.2 Materials and Methods
5.2.1 VIC isolation
For RAVICs, 9 week old Male and Female Sprague-Dawley rats were purchased
from Harlan laboratory. The cell isolation was identical to part 4.2.1. Briefly, the rats
were euthanized using CO2 inhalation and the aortic valves were removed from the rat
hearts using a dissecting microscope. Each aortic valve was carefully cut into 5-6 pieces,
then placed into a culture plate and covered with media consisting of DMEM, 10% FBS,
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1% l-glutamine and 1% penicillin/streptomycin (Mediatech). The VICs from each sex
were used for experiments at passage 7.
For PAVICs, aortic valves of 4-5years old pigs were used for cell isolation. PAVIC
isolation process is identical to part 3.2.1. Briefly, aortic valves were dissected and
PAVICs were isolated by collagenase digestion from each cusp separately. The cells
were passaged at 90% confluency and used for experiments at 4 passages.
5.2.2 Culture under cyclic strain
In order to study the effect of cyclic strain on calcification, the RAVICs and
PAVICs were plated in collagen-I coated Bioflex® 6-well culture plates. First, the cells
were cultured under static condition for two days for the cells to adhere to the plates. For
experimental samples, calcifying culture media was then added consisting of betaglycerophosphate, ascorbic acid and dexamethasone in regular culture medium. The
culture plates were then placed into a commercial Flexcell® system (Flexcell
International Inc.) and stretched under 10% and 15% cyclic stretching. The controls wells
under stretch and static controls were cultured in regular media. All the samples were
collected for analysis after 7 days of stretching.
5.2.3 Alizarin red S staining
Calcific nodule formation and calcium precipitation was determined for each
sample using Alizarin red S staining [124]. First, the RAVICs and PAVICs were fixed
with 10% formalin and treated with alizarin red solutions at room temperature for 4 to 5
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minutes. The excess dye was washed off, and then the VICs were dehydrated with 100%
acetone for less than 1 minute. The stained samples were finally imaged at 10X
magnification; image analysis was performed using ImageJ software. For image analysis,
an average number of 36 images per well were imported into Image J. The color channel
on each image was split, and the threshold was adjusted to form a black and white image.
Finally, the area, area fraction, integrated density, and perimeter of each image were
measured.
5.2.4 ALP enzyme activity assay
The RAVICs were assessed for ALP upregulation using an ALP enzyme activity
assay. The steps were similar to part 3.2.6. Briefly, the cell layers were lysed in 400μm
RIPA buffer, a dye solution of 221 Alkaline buffer and phosphatase substrate (both from
Sigma) was added to the samples and the resulting absorbance was measured at 405 nm
using a BioTek H1 plate reader. The total ALP enzyme was normalized to protein content
measured using BCA assay (kit purchased from Fisher Scientific, data not shown here).
5.2.5 statistical analysis
Statistical significance was determined using one-way ANOVA. A p-value of ≤0.05 was
considered significant.
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5.3 Results
5.3.1 Greater nodule formation and nodule size in male RAVICs than female
under pathological cyclic strain
The calcified nodules in RAVICs stained by alizarin red S show greater amount of
calcific deposition in male than female. Figure 5.1A shows representative images of
calcific nodules in male and female RAVICs cultured under 10% and 15% cyclic strain
for 7 days in osteogenic media. We found that the nodule parameters were significantly
greater for pathological strain (15%) only in male RAVICs. Moreover, the normalized
percentage of area covered with calcific nodules and normalized integrated density to
their respective static controls in osteogenic media were significantly greater for male
RAVICs compared to female (Figure 5.1 B,C). Similarly, the normalized nodule size to
static control in osteogenic media was greater in male RAVICs compared to female under
pathological strain (15%) after 7 days in osteogenic media. Interestingly, the pathological
strain increased the size of the nodules for both female and male RAVICs compared to
physiological strain. We did not observe any nodule formation in the controls under all
levels of strain in regular media.
5.3.2 Elevated early calcific marker expression in male RAVICs compared to
female under pathological cyclic strain
The ALP enzyme activity increased under pathological strain (15%) for both
female and male RAVICs, however the normalized ALP content in RAVICs under
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Figure 5.1 (A) Calcific nodules in male and female VICs as measured using alizarin red
staining. Scale bar is 100 μm. greater normalized nodule (B)area percentage(C) integrated
density and (D) size in male RAVICs compared to female under 15% cyclic strain. data
represent mean ± std. error, n=2 rat pairs. ⃰ indicates p<0.05 compared to female.
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pathological strain was greater in male RAVICs compared to female to respective
controls in static condition after 7 days in osteogenic media (Figure 5.2). Moreover, our
data for control samples under cyclic stretch cultured in regular media for 7 days show
expression of ALP enzyme in all the samples, however male controls showed increased
amounts of ALP enzyme compared to female at similar levels of strain (data not shown).

Figure 5.2 Fold change in ALP enzyme activity under 10 and 15% cyclic strain
normalized to respective controls in static condition after 7 days in osteogenic media. The
data represents mean ± std. error.

5.3.3 Greater calcification in PAVICs isolated from noncoronary cusps under
pathological cyclic strain
Alizarin red S staining of the calcified nodules among PAVIC monolayers after
being stretched for 7 days in osteogenic media showed that calcific nodules were formed
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in all the PAVICs from left, right and non-coronary under both physiological and
pathological levels of strain. Figure 5.3A and B show representative images of nodules in
PAVICs isolated from each aortic cusp and cultured under 15% stretch in osteogenic
media. Moreover, no nodules were formed in respective controls under strain in regular
media; however, nodules were observed in controls in static condition. The noncoronary
PAVICs showed increased nodule area percentage and integrated density normalized to
their respective statin control in osteogenic media under both physiological (10%) and
pathological cyclic strain (Figure 5.3C,D).

5.4 Discussion
In this study, we observed that male VICs form greater amount of calcific nodules
compared to female VICs under pathological levels of cyclic stretch. The nodule
formation is an indicator of early cell accumulation, which triggers cell differentiation
into diseased phenotypes. Similarly, male VICs demonstrated elevated ALP enzyme
expression compared to female under pathological levels of strain.
Aortic valve cusps are in direct contact with the high-pressure blood flow pumped
out of the left ventricle; Additionally, after the valve closes that blocks the blood
backflow into the ventricle, high pressure is applied to the aortic cusps. At both stages,
aortic cusps are stretched which subjects residing VICs to cyclic strain.
Our results support than male is at higher risk of calcification than female, and this
risk is greater under pathological stretch as observed in hypertension. Further
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Figure 5.3 (A) Representative images of stained nodules in VICs isolated from left, right
and noncoronary aortic cusps under 15% cyclic strain for 7 days in osteogenic media.
Scale bar is 250μm. (B) single nodules of left, right and noncoronary VICs under 15%
cyclic strain. scale bar is 100μm. (C) Fold change in area percentage and (D) nodule size
o VICs from left, right and noncoroanry aortic cusps cultured under 10 and 15% cyclic
strain in osteogenic media normalize to respective static control. The data represent mean
± std. error.
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investigation on these cell types is required to fully understand the interplay between sex
and cyclic stretch in aortic valve disease.
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CHAPTER SIX
CONCLUSIONS AND SUMMARY
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Studying the calcific aortic valve disease (CAVD) on different levels has recently
gained considerable attention. This is due to interesting characteristics of the aortic valves
and CAVD’s pathogenesis: first, the aortic valve cusps have a highly complicated
structure within a very small thickness. Three thin layers- Fibrosa, Spongiosa, and
Ventricularis- have varying amounts of collagen fibers and cell densities, each with a
specific role in aortic valve function. Second, the VICs in the adult aortic valve have a
heterogeneous population. A certain sub-phenotype (mesenchymal progenitor VICs)
show differentiation capabilities into osteoblast-like cells under pathological condition.
Third, CAVD has prominent risk factors with extensive prevalence like age, male sex,
renal disease, etc. The knowledge on the pathological mechanism linking these risk
factors to CAVD progression is very limited. Particularly the molecular biology behind
contribution of male sex to greater risk of this disease remains unknown. Fourth, aortic
valves are anatomically located in a very dynamic environment. The highest number of
clinical heart valve disorders in human belongs to aortic valve. Aortic valve cusps are in
direct contact with the high-pressure blood flow which subjects residing VICs to cyclic
strain at each systole and diastole.
Male is a risk factor in a number of major cardiovascular diseases; however, limited
research have been performed to understand the molecular and cellular mechanisms
exposing male to greater risk of cardiovascular disorders. In chapter 2, the previous
studies on sex-related differences in aortic stenosis, mitral valve prolapse and
atherosclerosis have been reviewed. We learned that aortic valve stenosis and
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atherosclerosis share number of major characteristics such as activation of endothelial
cells and macrophage infiltration at the initial stages, osteogenic differentiation into
osteoblast-like cells, etc.
In chapter 3, the difference in calcification among individual aortic cusps was
determined at a cellular level. It is known that noncoronary cusp and commissures are the
preferred site for CAVD initiation. VICs were isolated separately from porcine aortic
cusps and cultured in osteogenic condition for up to 14 days, then calcific markers
expression and ECM remodeling were measured for each group. We found that VICs
isolated from noncoronary cusps demonstrated greater calcific markers expression and
nodule formation. In addition, elevated ECM remodeling enzymes were present within
noncoronary VICs. We suggest that there might be an inherent different in the VICs
characteristics in each aortic cusp or a subpopulation of VICs that is predisposed to
calcification might be present at different densities among coronary and noncoronary
cusps.
In chapter 4, the greater risk of aortic valve calcification in male sex was assessed
at a cellular level. To our knowledge, this is the first study to assess the cellular
differences between male and female in the events associated with aortic valve
calcification. VICs were isolated from male and female rat aortic valves and cultured in
osteogenic media for up to 20 days. Our results confirmed the hypothesis that sex-related
differences exist between the male and female VICs cultured in pathological condition.
The VICs isolated from male aortic valves showed greater amounts of matrix synthesis
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and remodeling. Moreover, early calcific markers were upregulated in male VICs more
significantly than female. Neither of the male or female VICs showed nodule formation
or mineral deposition even after 20 days of osteogenic culture. We suggest that VICs in
male or female aortic valves might be inherently different, or maybe the different heart
sizes between male and female enforce greater mechanical forces to male and cause
different cell densities of VIC sub-phenotypes between male and female.
In chapter 5, we tested both studies of the previous chapters under cyclic strain to
verify whether application of cyclic strain enhances the calcification of the VICs and the
differences observed in the previous studies. VICs isolated from male and female rat and
porcine aortic valves were cultured in collagen I-coated Bioflex® culture plates and
subjected to physiological (10%) and pathological (15%) cyclic stretch using a flexcell®
system. Our results showed increased calcific marker expression in male VICs after
normalizing to respective controls cultured in static condition in osteogenic media for
similar length of time (7 days). In addition, control samples that were under similar cyclic
strain and in regular media showed no nodule formation. It is confirmative that
pathological levels of cyclic stretch enhances the calcification of male VICs more
significantly than female when cultured in osteogenic media. We suggest that
pathological cyclic strain individually does not initiate the VICs osteogenic
differentiation where there are no biochemical factors in the environment. We conclude
that calcification of VICs in the native tissue might be caused by combination of
pathological mechanical forces and inflammatory or degenerative enzymes in the ECM.
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This dissertation provides comparative studies on VICs calcification potential from
different aortic valve locations or sexes. Research presented in this dissertation could
have great impact on analyzing the molecular events associated with aortic valve
calcification, providing differences on the VICs characteristic where no growth factor
was added to the cells to elevate the calcification. The results provided in this dissertation
can change the experimental approaches in the studies on aortic valve calcification, and
in the future, necessitate different treatments for CAVD patients based on their gender
and clinical history.
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In chapter 4, it was mentioned that no nodule formation or mineral deposition were
observed within the VICs isolated from male or female rat aortic valves even after up to
20 days of culture in osteogenic media. We decided to repeat the tests for VICs isolated
from male and female porcine aortic valves. VICs isolation and culture methods were
similar to part 3.2.1. Next, the male and female PAVICs were stained for alizarin red S
and Von Kossa using methods similar to part 3.2.4. Our results showed nodule formation
and mineral deposition in PAVICs from both sexes.
Images of male and female VICs from rat and porcine aortic valves stained for Von
Kossa indicated that mineral deposition occurs in porcine VICs and not in rat VICs
(Figure Ap.1).
Images of male and female rat and porcine VICs stained for alizarin red S
demonstrated the abundance of calcific nodules within porcine VICs; however no
nodules was formed in rat VICs (Figure Ap.2).
This project is still ongoing; however the results we obtained so far suggest that
there might be a difference among species in the events associated with aortic valve
calcification. Further investigation is required to confirm this hypothesis.
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Figure 6.1 Mineral deposition among male and female VICs isolated from rat and porcine
aortic valves after 15 days of culture in osteogenic media. Scale bar is 250μm.
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Figure 6.2 Calcific nodules among male and female VICs isolated from rat and porcine
aortic valves after 15 days of culture in osteogenic media. Scale bar is 250μm.
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In chapter 4, it was mentioned that VICs have also been isolated and cultured from
aged rats (30 weeks); however, they did not grow to a large population and stopped
growing after 3 passages. Therefore, we were not able to perform the experiments on
aged VICs to determine their calcification. Figure Ap. 3A,B show representative images
of the female and male aged rat VICs, respectively.

Figure 6.3 Representative images of VICs isolated from (A) female and (B) male aged rat
aortic valves after 2 passages. Scale bar is 250μm.
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